Some tips on 486-73-7

486-73-7 Isoquinoline-1-carboxylic acid 68092, aisoquinoline compound, is more and more widely used in various.

486-73-7, Isoquinoline-1-carboxylic acid is a isoquinoline compound, ?involved in a variety of chemical synthesis. Rlated chemical reaction is continuously updated

General procedure: To a solution of carboxylic acid (1.0 mmol) in anhydrous THF (20 mL) were added (2S,3R)-2-amino-3-hydroxy-N-alkylbutanamide 4a-d (1.0 mmol) and HOBt (1.0 mmol, 0.135 g) at 0 C. After the reaction mixture was stirred for 5 min, EDC¡¤HCl (0.220 g, 1.1 mmol) was added. The pH value of the solution was adjusted to 8-9 with 4-methylmorpholine. The reaction mixture was stirred at 0 C for 2 h and overnight at room temperature. After evaporation of the mixture in vacuo, the residue was dissolved in ethyl acetate (50 mL). The solution was washed successively with saturated NaHCO3, 5% KHSO4, and saturated NaCl. The organic phase was separated and dried over anhydrous MgSO4. After filtration and evaporation in vacuo, residue was purified by recrystallization in petroleum ester/ethyl acetate to give the desired ceramide analogues 5xa-xj.

486-73-7 Isoquinoline-1-carboxylic acid 68092, aisoquinoline compound, is more and more widely used in various.

Reference£º
Article; Liu, Qianqian; Li, Xia; Bao, Yong-Sheng; Lu, Jingxin; Li, Hua; Huang, Zhizhen; Liu, Feiyan; Bioorganic and Medicinal Chemistry; vol. 27; 8; (2019); p. 1489 – 1496;,
Isoquinoline – Wikipedia
Isoquinoline | C9H7N – PubChem

 

Some tips on 1125-80-0

1125-80-0 3-Methylisoquinoline 14306, aisoquinoline compound, is more and more widely used in various.

With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.1125-80-0,3-Methylisoquinoline,as a common compound, the synthetic route is as follows.

The mixture of 3-methylisoquinoline (782 mg, 5.46mmol), N-bromosuccinimide (1.069 g, 6.01 mmol) and azobisisobutyronitrile (134 mg, 0.819mmol) in CCl4 (100 mL) were refluxed for 1 h. Ten percent of Na2S2O3 (20 mL) was then addedto quench the reaction. The mixture was diluted with DCM (20 mL). The organic layer wasseparated and washed with brine, dried over Na2SO4 and concentrated. To the residue was added12DCM, the precipitate was filtered off and the filtrate was purified with silica gel (EA/PE = 1/20)to give 387 mg white solid, in 32% yield. 1H NMR (400 MHz, CDCl3) 9.25 (s, 1H), 7.98 (d, J= 8.04 Hz, 1H), 7.82 (d, J = 8.06 Hz, 1H), 7.77 (s, 1H), 7.71 (m, 1H), 7.62 (m, 1H), 4.75 (s, 2H);13C NMR (100 MHz, CDCl3) delta 152.92, 150.10, 136.26, 130.84, 127.94, 127.83, 127.65, 126.67,119.77, 34.63. IR (Diamond, cm-1) numax 3058.1, 1627.5, 1218.2, 956.0, 893.9, 753.4, 733.1. mp 90.5 – 92 C.

1125-80-0 3-Methylisoquinoline 14306, aisoquinoline compound, is more and more widely used in various.

Reference£º
Article; Yuan, Yunyun; Elbegdorj, Orgil; Beletskaya, Irina O.; Selley, Dana E.; Zhang, Yan; Bioorganic and Medicinal Chemistry Letters; vol. 23; 18; (2013); p. 5045 – 5048;,
Isoquinoline – Wikipedia
Isoquinoline | C9H7N – PubChem

 

Brief introduction of 22246-12-4

As the paragraph descriping shows that 22246-12-4 is playing an increasingly important role.

With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.22246-12-4,6-Methoxy-3,4-dihydroisoquinolin-1(2H)-one,as a common compound, the synthetic route is as follows.

Example 5 (E)-methyl 3 -(4-(6-hydroxy-2-(4-isopropoxyphenyl)-l -methyl- 1.2.3.4-tetrahvdroisoquinolin-l- vD-phenvDacrylate 6-methoxy-3,4-dihydroisoquinolin-l(2H)-one (0.21 g, 1.185 mmol) was dissolved dichloromethane (5.93 ml). A I M solution of BBr3 (5.93 ml, 5.93 mmol) in heptanes was added dropwise and the reaction stirred for 30 min at rt. LC MS indicates the reaction was 50% complete, additional 1 M BBr3 in heptanes (5.93 ml, 5.93 mmol) was added. The reaction stirred for 1 h at rt. The reaction was then quenched with saturated sodium bicarbonate. The reaction was extracted with DCM but DCM extract did not contain any product. The product precipitated out on the reaction flask and was collected. The crude product was used without purification in the next reaction. NMR (400 MHz, DMSO-d6) delta 7.67 (d, J = 8.4 Hz, 1H), 6.69 (dd, J = 8.4, 2.4 Hz, 1H), 6.62 (d, J = 2.4 Hz, 1H), 3.31 (t, J = 6.1 Hz, 2H), 2.79 (t, J = 6.6 Hz, 2H). LC/MS (m/z, MH+): 164.1.

As the paragraph descriping shows that 22246-12-4 is playing an increasingly important role.

Reference£º
Patent; NOVARTIS AG; BURKS, Heather Elizabeth; KARKI, Rajeshri Ganesh; KIRBY, Christina Ann; NUNEZ, Jill; PEUKERT, Stefan; SPRINGER, Clayton; SUN, Yingchuan; THOMSEN, Noel Marie-france; WO2015/92634; (2015); A1;,
Isoquinoline – Wikipedia
Isoquinoline | C9H7N – PubChem

 

Simple exploration of 147497-32-3

147497-32-3 6-Bromo-3,4-dihydroisoquinolin-1(2H)-one 21865450, aisoquinoline compound, is more and more widely used in various.

147497-32-3, 6-Bromo-3,4-dihydroisoquinolin-1(2H)-one is a isoquinoline compound, ?involved in a variety of chemical synthesis. Rlated chemical reaction is continuously updated

EXAMPLE11; Step 11A;: A mixture of 6-bromo-3,4-dihydro-2H-isoquinolin-1-one (250 mg, 1.11 mmol), 4-trifluoromethyl-phenyl-boronic acid (251 mg, 1.33 mmol), 2 M aqueous sodium carbonate (1.10 mL), toluene (6 mL), ethanol (2 mL) and water (1 mL) was purged with nitrogen for 5 minutes. Palladium-tetrakis (triphenylphosphine) (64 mg, 0.055 mmol) was added and the mixture was heated with stirring at 80 C in a sealed pressure vessel for 19 h. Water (1 mL) was added and the reaction mixture was extracted with ethyl acetate (3 x 5 mL). The combined organic fractions were rinsed with water (10 mL) and concentrated in vacuo to give 475 mg of a light orange solid. Chromatography (silica gel 4: 96: 0.5, methanol: CH2Cl2: NH40H) afforded 189 mg (59 %) of lla as an off-white solid. LC-MS 292.0 (MH+).

147497-32-3 6-Bromo-3,4-dihydroisoquinolin-1(2H)-one 21865450, aisoquinoline compound, is more and more widely used in various.

Reference£º
Patent; NEUROCRINE BIOSCIENCES, INC.; WO2005/103039; (2005); A1;,
Isoquinoline – Wikipedia
Isoquinoline | C9H7N – PubChem

 

Simple exploration of 22246-12-4

The synthetic route of 22246-12-4 has been constantly updated, and we look forward to future research findings.

With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.22246-12-4,6-Methoxy-3,4-dihydroisoquinolin-1(2H)-one,as a common compound, the synthetic route is as follows.

To a solution of 6-methoxy-1-oxo-1,2,3,4-tetrahydroisoquinoline (31.3 g, 177 mmol) in CH2 Cl2 (300 mL) at -78 is added BBr3 (33.4 mL, 353 mmol). The reaction mixture is allowed to come to ambient temperature and is stirred for 12 hours. After this time the reaction mixture is cooled to 0 and is subsequently neutralized with 5N NaOH (150 mL) solution and saturated NaHCO3 solution. The resulting precipitate is extracted with hot acetone (4*500 mL) and the combined organics are concentrated in vacuo to give 6-hydroxy-1-oxo-1,2,3,4-tetrahydroisoquinoline.

The synthetic route of 22246-12-4 has been constantly updated, and we look forward to future research findings.

Reference£º
Patent; Ciba-Geigy Corporation; US5334600; (1994); A;; ; Patent; Ciba-Geigy Corporation; US5260316; (1993); A;,
Isoquinoline – Wikipedia
Isoquinoline | C9H7N – PubChem

 

Brief introduction of 486-73-7

The synthetic route of 486-73-7 has been constantly updated, and we look forward to future research findings.

With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.486-73-7,Isoquinoline-1-carboxylic acid,as a common compound, the synthetic route is as follows.

The crude residue obtained from the procedure herein above is combined with 1-isoquinolinecarboxylic acid (2.6 g, 15.0 mmol), HOBt (2.68 g, 19.8 [MMOL),] and EDCI (3.8 g, 19.8 [MMOL)] in DMF (20 mL). The solution is stirred for 3 hours at room temperature then diluted with EtOAc, washed with saturated [NAHCO3,] saturated NaCI, and dried (Na2SO4). The solvent is removed in vacuo and the residue obtained purified by HPLC to afford 1.7 g (40% yield) of the desired product NMR [(CDCI3)] 8 9.49-9. 46 (d, J=7.8 Hz, [1H),] 9.20-9. 18 (d, J=6.9 Hz, 1H), 8.52-8. 50 (d, J=5.5 Hz, [1H),] 7.86-7. 78 (m, 2H), 7.72-7. 63 (m, 2H), 5.79 (bs, [1H),] 5.55-5. 47 (m, [1H),] 4.76-4. 69 (d, d, [J=17.] 3,2. 3 Hz, [1H),] 4.45-4. 40 (d, [J=17.] 4 Hz, 1H), 4.25-4. 19 (d, [J=17.] 4 Hz, [1H),] 4.15-3. 98 (m, 3H), 3.73 (s, 3H), 3.65-3. 59 (d, [J=17.] 4 Hz, [1H),] 2.97-2. 90 (d, d, [J=18.] 2,3. 9 Hz, 1H), 2.48-2. 29 (m, 3H) [;’3C (CDCI3) S] 172.7, 170.5, 165.9, 148.2, 141.0, 137.7, 136.3, 130.7, 128.9, [127?7,] 127.2, 126.4, 124.7, 67.5, 60.8, 52.8, 50.3, 49.3, [48.] 1,32. 5,21. 4,14. 5; MS 384 (M+H) [+.]

The synthetic route of 486-73-7 has been constantly updated, and we look forward to future research findings.

Reference£º
Patent; THE PROCTER & GAMBLE COMPANY; WO2003/103677; (2003); A1;,
Isoquinoline – Wikipedia
Isoquinoline | C9H7N – PubChem

 

New learning discoveries about 1125-80-0

As the paragraph descriping shows that 1125-80-0 is playing an increasingly important role.

With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.1125-80-0,3-Methylisoquinoline,as a common compound, the synthetic route is as follows.

Preparation 1-9 3-Methyl-1,2,3,4-Tetrahydroisoquinoline 3.0 g of 3-methylisoquinoline(21 mM) and 50 ml of methanol were mixed and 0.84 g of platinum oxide was added thereto. The mixture was subjected to hydrogenation at 40 psi and filtered. The filtrate was concentrated under a reduced pressure, to give 3.3 g of the title compound.

As the paragraph descriping shows that 1125-80-0 is playing an increasingly important role.

Reference£º
Patent; Yuhan Corporation; US5686458; (1997); A;,
Isoquinoline – Wikipedia
Isoquinoline | C9H7N – PubChem

 

Simple exploration of 2412-58-0

As the paragraph descriping shows that 2412-58-0 is playing an increasingly important role.

2412-58-0, 1-Methyl-3,4-dihydroisoquinoline is a isoquinoline compound, ?involved in a variety of chemical synthesis. Rlated chemical reaction is continuously updated

(10-3) 1.0 g of 1-methyl-3,4-dihydroisoquinoline was dissolved in 7.0 ml of conc. nitric acid at 0 C., and 14.0 ml of fuming nitric acid was added dropwise to the solution. The solution was stirred for one hour at the same temperature, and overnight at room temperature. The reaction mixture was poured into ice, neutralized with aqueous solution of sodium hydroxide, and extracted with ethyl acetate. The organic layer was washed with saturated aqueous solution of sodium chloride, and dried with anhydrous sodium sulfate. The desiccant was separated by filtration, and the filtrate was purified by silica gel column chromatography to obtain 1.08 g of 1-methyl-7-nitro-3,4-dihydroisoquinoline, which was white crystal (yield: 82%).

As the paragraph descriping shows that 2412-58-0 is playing an increasingly important role.

Reference£º
Patent; Terumo Kabushiki Kaisha; US5789595; (1998); A;,
Isoquinoline – Wikipedia
Isoquinoline | C9H7N – PubChem

 

Downstream synthetic route of 147497-32-3

As the paragraph descriping shows that 147497-32-3 is playing an increasingly important role.

147497-32-3, 6-Bromo-3,4-dihydroisoquinolin-1(2H)-one is a isoquinoline compound, ?involved in a variety of chemical synthesis. Rlated chemical reaction is continuously updated

To a solution of the title A compound, 6-BROMO-3, 4-DIHYDRO-2H-ISOQUINOLIN-1-ONE (570 mg, 2.52 mmol) and benzyl bromide (390 UL, 3.28 mmol) in 10 mL of DMF is added sodium hydride (131 mg, 3.28 MMOL), and the reaction is stirred at RT for 3 h. The reaction is quenched with 1 N aqueous HCI, and the product is taken up in EtOAc. The organic solution is washed with water and brine, dried over anhydrous NA2SO4 and concentrated : Chromatography on silica (eluent : EtOAc/hexane – 1) affords 2-BENZYL-6-BROMO-3, 4-dihydro- 2H-isoquinolin-1-one.

As the paragraph descriping shows that 147497-32-3 is playing an increasingly important role.

Reference£º
Patent; NOVARTIS AG; NOVARTIS PHARMA GMBH; WO2004/65351; (2004); A1;,
Isoquinoline – Wikipedia
Isoquinoline | C9H7N – PubChem

 

Simple exploration of 147497-32-3

147497-32-3 6-Bromo-3,4-dihydroisoquinolin-1(2H)-one 21865450, aisoquinoline compound, is more and more widely used in various.

147497-32-3, 6-Bromo-3,4-dihydroisoquinolin-1(2H)-one is a isoquinoline compound, ?involved in a variety of chemical synthesis. Rlated chemical reaction is continuously updated

b) Compound B (0.5 g, 2.21 mmol) was dissolved in dry DMF (3 mL) and 60% sodium hydride was added on ice bath(1.76 g, 4.42 mmol), stirred for 30 minutes, and added methyl 4-bromomethyl benzoate (0.557 g, 2.23 mmol).Stir at room temperature for 1 hour, pour into 100 mL crushed ice, extract with ethyl acetate (100 mL*3), combine the organic layers, and in turn water100 mL of 100 mL of saturated brine was extracted and dried over anhydrous sodium sulfate. The residue was purified by flash silica gel column chromatography usingElution with oleyl ether/ethyl acetate (V/V=5:1) gave compound C (0.74 g) as a pale yellow solid with a yield of 90%.

147497-32-3 6-Bromo-3,4-dihydroisoquinolin-1(2H)-one 21865450, aisoquinoline compound, is more and more widely used in various.

Reference£º
Patent; Chinese Academy Of Sciences Shanghai Pharmaceutical Institute; Shen Jingkang; Xiong Bing; Zhao Lele; Li Jia; Geng Meiyu; Ma Lanping; Chen Danqi; Su Mingbo; Zhou Yubo; Hu Xiaobei; Liu Hongchun; Shen Aijun; (54 pag.)CN107879975; (2018); A;,
Isoquinoline – Wikipedia
Isoquinoline | C9H7N – PubChem